Copyright
©The Author(s) 2016.
World J Hepatol. Apr 8, 2016; 8(10): 499-508
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.499
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.499
Figure 1 Tyrosine predicts 3-mo liver transplant-free survival in patients with end-stage liver disease.
Results are presented as AUC (P25, P75). AUC: Area under receiver operating characteristics curve; OLT: Orthotopic liver transplantation; MELD: Model for end-stage liver disease.
- Citation: Ascha M, Wang Z, Ascha MS, Dweik R, Zein NN, Grove D, Brown JM, Marshall S, Lopez R, Hanouneh IA. Metabolomics studies identify novel diagnostic and prognostic indicators in patients with alcoholic hepatitis. World J Hepatol 2016; 8(10): 499-508
- URL: https://www.wjgnet.com/1948-5182/full/v8/i10/499.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i10.499